Similar articles for PMID: 19952293

Year	Number of Results
2000	1
2004	2
2005	6
2006	10
2007	9
2008	14
2009	9
2010	1
2014	1
2022	0

1

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?

Messerli FH, Yuzefpolskaya M. Messerli FH, et al. Cleve Clin J Med. 2009 Dec;76(12):693-6. doi: 10.3949/ccjm.76a.09052. Cleve Clin J Med. 2009. PMID: 19952293 Free article.

2

Dual blockade of the renin-angiotensin system for cardiorenal protection: an update.

Arici M, Erdem Y. Arici M, et al. Am J Kidney Dis. 2009 Feb;53(2):332-45. doi: 10.1053/j.ajkd.2008.11.021. Am J Kidney Dis. 2009. PMID: 19166800 Review.

3

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR. Weir MR. Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.

4

New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Weber MA. Weber MA. Am J Cardiol. 2007 Aug 6;100(3A):45J-52J. doi: 10.1016/j.amjcard.2007.05.014. Epub 2007 May 25. Am J Cardiol. 2007. PMID: 17666198 Review.

5

The hazards of dual renin-angiotensin blockade in chronic kidney disease.

Ku E, Park J, Vidhun J, Campese V. Ku E, et al. Arch Intern Med. 2009 Jun 8;169(11):1015-8. doi: 10.1001/archinternmed.2009.128. Arch Intern Med. 2009. PMID: 19506167 No abstract available.

6

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R. Epstein BJ, et al. Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Expert Rev Cardiovasc Ther. 2009. PMID: 19900020 Review.

7

Is there added value to adding ARB to ACE inhibitors in the management of CKD?

Cohen DL, Townsend RR. Cohen DL, et al. J Am Soc Nephrol. 2009 Aug;20(8):1666-8. doi: 10.1681/ASN.2008040381. Epub 2008 Sep 5. J Am Soc Nephrol. 2009. PMID: 18776118 Free article.

8

Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.

Song JH, Cha SH, Hong SB, Kim DH. Song JH, et al. J Hypertens Suppl. 2006 Mar;24(1):S101-6. doi: 10.1097/01.hjh.0000220414.99610.6b. J Hypertens Suppl. 2006. PMID: 16601562 Review.

9

Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.

Toto R, Palmer BF. Toto R, et al. Am J Nephrol. 2008;28(3):372-80. doi: 10.1159/000112269. Epub 2007 Dec 12. Am J Nephrol. 2008. PMID: 18073461 Free article. Review.

10

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G. Catapano F, et al. Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12. Am J Kidney Dis. 2008. PMID: 18468748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed